Ozempic is FDA-approved exclusively for adults with type 2 diabetes. Despite its popularity as a weight loss drug, the official criteria center on blood sugar control, cardiovascular protection, and kidney disease in people who already have a type 2 diabetes diagnosis. Getting it covered by insurance adds another layer of requirements, and certain medical conditions disqualify you entirely.
FDA-Approved Uses
The FDA has approved Ozempic (semaglutide) for three specific purposes, all in adults with type 2 diabetes:
- Blood sugar management: As an add-on to diet and exercise to improve blood sugar control.
- Heart disease risk reduction: To lower the risk of major cardiovascular events, including heart attack, stroke, and cardiovascular death, in people who also have established heart disease.
- Kidney protection: To reduce the risk of kidney function decline, end-stage kidney disease, and cardiovascular death in people who also have chronic kidney disease.
Notice that weight loss is not on the list. Ozempic is not FDA-approved for obesity or weight management. The closely related drug Wegovy uses the same active ingredient at a higher dose and is the version approved for weight loss. This distinction matters for both medical eligibility and insurance coverage.
Ozempic Is Not Approved for Children
Safety and effectiveness in pediatric patients have not been established for Ozempic. Wegovy, the weight management version of semaglutide, is approved for people aged 12 and older with obesity, but Ozempic itself carries no pediatric indication. A CDC review of adolescent obesity prescriptions from 2018 to 2023 specifically excluded Ozempic from its list of obesity medications because it is indicated for type 2 diabetes, not weight loss.
What Insurance Companies Require
Even with a type 2 diabetes diagnosis, most insurers require prior authorization before they’ll cover Ozempic. UnitedHealthcare’s criteria offer a representative example of what you’ll typically need to provide.
Your medical records must confirm a type 2 diabetes diagnosis through one of these lab values:
- A1C: 6.5% or higher
- Fasting blood sugar: 126 mg/dL or higher
- Oral glucose tolerance test: 200 mg/dL or higher at the two-hour mark
- Random blood sugar: 200 mg/dL or higher with classic symptoms of high blood sugar
If you were diagnosed more than two years ago, insurers may accept chart notes confirming your ongoing diabetes diagnosis without requiring fresh lab work. The key takeaway: you’ll need documented proof of type 2 diabetes, not just a prescription from your doctor.
UnitedHealthcare’s policy states explicitly that medications used for weight loss purposes are “typically excluded from benefit coverage.” Most major insurers follow similar logic. If your provider writes an Ozempic prescription for weight management rather than diabetes, expect a denial.
Who Cannot Take Ozempic
Ozempic is contraindicated, meaning it should not be used at all, in two specific groups:
- Personal or family history of medullary thyroid carcinoma (MTC): This is a rare type of thyroid cancer. If you or a blood relative have been diagnosed with it, Ozempic is off the table.
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2): This inherited condition raises the risk of certain tumors, including medullary thyroid cancer. Anyone with this diagnosis is disqualified.
These restrictions exist because semaglutide caused thyroid tumors in animal studies. While it’s unclear whether the same risk applies to humans, the FDA treats these two conditions as absolute contraindications.
Off-Label Prescribing for Weight Loss
Doctors can legally prescribe Ozempic off-label for weight loss, and many do. The typical BMI thresholds used in weight management, a BMI of 30 or above (or 27 with a weight-related condition like high blood pressure or sleep apnea), come from the FDA criteria for Wegovy, not Ozempic. Providers who prescribe Ozempic for weight loss are borrowing those guidelines informally.
The practical catch is cost. Without insurance coverage, Ozempic runs well over $900 per month at retail price. Since insurers generally won’t cover it for weight loss, many people prescribed off-label pay entirely out of pocket. Some manufacturer savings programs exist, but they typically apply only to the on-label diabetes indication.
How the Dosing Schedule Works
Ozempic is a once-weekly injection. Everyone starts at a low dose to let the body adjust, then gradually moves up. The starting dose is 0.25 mg per week for the first four weeks. This phase is purely for tolerability and isn’t expected to have a strong effect on blood sugar. After four weeks, the dose increases to 0.5 mg weekly. If additional blood sugar control is needed after at least four more weeks, your provider can raise it to 1 mg and eventually to 2 mg per week.
The decision to increase depends on how well your blood sugar responds and how you tolerate side effects, primarily nausea, which is most common during dose increases. Not everyone needs to reach the highest dose. Many people achieve adequate blood sugar control at 0.5 mg or 1 mg.
What Qualifies You in Practice
Putting it all together, qualifying for Ozempic in a real-world medical setting typically means you are an adult with a confirmed type 2 diabetes diagnosis, you have lab results that meet your insurer’s threshold, you have no personal or family history of medullary thyroid cancer or MEN 2, and your provider believes a GLP-1 medication is appropriate for your treatment plan. For the cardiovascular or kidney protection indications, you’ll also need a documented history of heart disease or chronic kidney disease alongside your diabetes diagnosis.
If you’re primarily interested in weight loss and don’t have type 2 diabetes, Wegovy is the version of semaglutide designed and approved for that purpose, with its own set of prescribing criteria and a separate (though often equally complicated) insurance approval process.